-
Diagnostics World News | Personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease to improve their health outcomes; state-of-the-art AI algorithms provide a real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients; bioelectronic sensors that will aid in cheap, accurate, and rapid pathogen detection; and more.
Mar 30, 2023
-
Diagnostics World News | Funding for targeting extracellular proteins involved in the pathogenesis of autoimmune, neurological, and other diseases, rapid screening of infectious diseases through volatile organic compounds, a proteomics AI-based platform that comprehensively maps the course of a disease to predict which patients will respond to a given drug, and more.
Mar 28, 2023
-
Diagnostics World News | A research team from the Nagoya University Graduate School of Medicine, Japan, discovered three gut bacteria types that may lead to predicting and treating dementia with Lewy bodies.
Mar 23, 2023
-
Diagnostics World News | A smartphone-based app and test kit for lupus nephritis may start making its way to neighborhood CVS and Walgreens stores in another few years. The urine test has been shown to detect the protein ALCAM (activated leukocyte cell adhesion molecule) to distinguish lupus patients with and without the condition with 86% accuracy in multiple cohorts.
Mar 22, 2023
-
Diagnostics World News | The worlds of genetics, epigenetics, and artificial intelligence have united to enable development of a blood test for the early detection of coronary heart disease. Newly launched in the U.S. by Cardio Diagnostics, PrecisionCHD is underpinned by the same technology as the company’s predecessor Epi+Gen CHD risk assessment test but using a different set of genetic and DNA methylation biomarkers.
Mar 21, 2023
-
Diagnostics World News | An array of diagnostics companies have set their sights on developing minimal residual disease tests capable of detecting low levels of cancer cells remaining in the body following surgery or other types of treatment. The aim is to help measure response to therapy and identify patients at risk of relapse.
Mar 16, 2023